These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32580098)

  • 1. Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment.
    Xu Y; De Keersmaecker H; Braeckmans K; De Smedt S; Cani PD; Préat V; Beloqui A
    Biomaterials; 2020 Oct; 255():120209. PubMed ID: 32580098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel strategy for oral peptide delivery in incretin-based diabetes treatment.
    Xu Y; Van Hul M; Suriano F; Préat V; Cani PD; Beloqui A
    Gut; 2020 May; 69(5):911-919. PubMed ID: 31401561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size Effect on Lipid Nanocapsule-Mediated GLP-1 Secretion from Enteroendocrine L Cells.
    Xu Y; Carradori D; Alhouayek M; Muccioli GG; Cani PD; Préat V; Beloqui A
    Mol Pharm; 2018 Jan; 15(1):108-115. PubMed ID: 29226685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs.
    Ismail R; Csóka I
    Eur J Pharm Biopharm; 2017 Jun; 115():257-267. PubMed ID: 28336368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Display of quintuple glucagon-like peptide 1 (28-36) nonapeptide on Bacillus subtilis spore for oral administration in the treatment of type 2 diabetes.
    Kang M; Feng F; Ge Q; Zhu F; Chen L; Lv P; Ma S; Yao Q; Chen K
    J Appl Microbiol; 2021 Feb; 130(2):314-324. PubMed ID: 32473615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incretin hormones: Their role in health and disease.
    Nauck MA; Meier JJ
    Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():5-21. PubMed ID: 29364588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretins: their physiology and application in the treatment of diabetes mellitus.
    Tasyurek HM; Altunbas HA; Balci MK; Sanlioglu S
    Diabetes Metab Res Rev; 2014 Jul; 30(5):354-71. PubMed ID: 24989141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide.
    Patterson S; de Kort M; Irwin N; Moffett RC; Dokter WH; Bos ES; Miltenburg AM; Flatt PR
    Diabetes Obes Metab; 2015 Aug; 17(8):760-70. PubMed ID: 25929155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel neurotensin/xenin fusion peptide enhances β-cell function and exhibits antidiabetic efficacy in high-fat fed mice.
    Perry RA; Craig SL; Gault VA; Flatt PR; Irwin N
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34370015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of incretin hormones and glucagon in patients with liver disease.
    Junker AE
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model.
    Shrestha N; Araújo F; Shahbazi MA; Mäkilä E; Gomes MJ; Airavaara M; Kauppinen EI; Raula J; Salonen J; Hirvonen J; Sarmento B; Santos HA
    J Control Release; 2016 Jun; 232():113-9. PubMed ID: 27091697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
    Nauck MA; Quast DR; Wefers J; Pfeiffer AFH
    Diabetes Obes Metab; 2021 Sep; 23 Suppl 3():5-29. PubMed ID: 34310013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: an overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines.
    Korish AA
    Horm Metab Res; 2014 Jun; 46(6):404-11. PubMed ID: 24627103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy.
    Araújo F; Shrestha N; Gomes MJ; Herranz-Blanco B; Liu D; Hirvonen JJ; Granja PL; Santos HA; Sarmento B
    Nanoscale; 2016 May; 8(20):10706-13. PubMed ID: 27150301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro.
    Liu YX; Si MM; Lu W; Zhang LX; Zhou CX; Deng SL; Wu HS
    J Ethnopharmacol; 2015 May; 166():168-75. PubMed ID: 25792018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
    Elahi D; McAloon-Dyke M; Fukagawa NK; Meneilly GS; Sclater AL; Minaker KL; Habener JF; Andersen DK
    Regul Pept; 1994 Apr; 51(1):63-74. PubMed ID: 8036284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretins play an important role in FFA4/GPR120 regulation of glucose metabolism by GW-9508.
    McKillop AM; Miskelly MG; Moran BM; Flatt PR
    Life Sci; 2023 Apr; 318():121475. PubMed ID: 36754346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1.
    Qu W; Li Y; Hovgaard L; Li S; Dai W; Wang J; Zhang X; Zhang Q
    Int J Nanomedicine; 2012; 7():4983-94. PubMed ID: 23028226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.